Cervical screening according to age and HPV status

BMJ (Online)

Volumn 339, Issue 7716, 2009, Pages 306-

  Ronco, Guglielmo ^a   Arbyn, Marc ^b   Segnan, Nereo ^a  

^a Centre for Cancer Prevention   (Italy)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

AGE DISTRIBUTION; CANCER CYTODIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; DEVELOPED COUNTRY; EDITORIAL; FEMALE; GENE OVEREXPRESSION; HUMAN; INFECTION RATE; INFECTION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT INDICATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DIAGNOSIS; WART VIRUS;

ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 69449102268     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3005     Document Type: Editorial

References (12)

1. Bulkmans NWJ, Berkhof J, Rozendall L, van Kemenade F, Boeke A, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-1772[CrossRef][Web of Science] [Medline] (Pubitemid 350137476)
2. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357:1589-1597 [Abstract/Free Full Text] (Pubitemid 47598401)
3. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Mayrand M-H, Dillner J, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26S:K29-41.
4. Castle PE, Rodrìguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009;339:b2569. [Abstract/Free Full Text]
5. Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, et al. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol 2008;9:937-945[CrossRef][Web of Science][Medline]
6. Sasieni P, Castanòn A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009;339:b2968.[Abstract/Free Full Text]
7. Franceschi S, Herrero R, Clifford G, Snijders PJ, Arslan A, Anh PT, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006;119:2677-2684 [CrossRef][Web of Science][Medline] (Pubitemid 44691325)
8. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez A C, Bratti MC, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191:1808-1816[CrossRef][Web of Science][Medline] (Pubitemid 40705386)
9. Woodman CI, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal study. Lancet 2001;357:1831-1836[CrossRef][Web of Science][Medline] (Pubitemid 32539115)
10. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006;7:547-555[CrossRef][Web of Science][Medline] (Pubitemid 43923665)
11. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Results at recruitment from a randomised controlled trial comparing human papillomavirus testing alone with conventional cytology as a primary cervical cancer screening test. J Natl Cancer Inst 2008;100:492-501. [Abstract/Free Full Text]
12. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284.[Abstract/Free Full Text]